Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Syndax Pharmaceuticals Inc Director's Dealing 2018

Sep 27, 2018

31977_dirs_2018-09-27_3f26b052-c8f6-4fbe-a7ab-791fbfcef8ac.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Syndax Pharmaceuticals Inc (SNDX)
CIK: 0001395937
Period of Report: 2018-09-25

Reporting Person: Meury William (N/A)

More from Syndax Pharmaceuticals Inc

Annual Report 2026
Apr 30
Proxy Solicitation & Information Statement 2026
Apr 30
Annual Report 2026
Feb 26
Regulatory Filings 2026
Feb 26
Director's Dealing 2026
Feb 10
Director's Dealing 2026
Feb 10
Director's Dealing 2026
Feb 6
Director's Dealing 2026
Feb 6
Director's Dealing 2026
Feb 6
Director's Dealing 2026
Feb 6
View all filings →